IRON YOU'LL ACTUALLY TAKE

What do iron deficiency and iron deficiency anemia feel like? 

Common symptoms of ID and IDA include: 

• Fatigue
• Pale skin
• Trouble breathing
• Headache
• Dizziness
• Chest pain
• Restless leg syndrome
• Dry and rough skin
• Hair loss
• Cravings for nonnutritive substances such as ice, dirt, or starch
• Cold hands and feet
• Poor concentration or memory
• Irritability
• Dry mouth

How are iron deficiency and iron deficiency anemia treated? 

If your doctor thinks you have ID or IDA, they may run blood tests to measure your hemoglobin, ferritin, and transferrin saturation (TSAT) levels.* Depending on your results, your doctor might prescribe oral iron supplements. Traditional oral iron supplements often cause GI side effects because they start breaking down in the stomach instead of the small intestine, where it is absorbed. 

• More than two-thirds of people taking traditional oral iron report GI issues such as heartburn, stomach cramps, loss of appetite, nausea, diarrhea, discolored stools, constipation, and gas.
• Up to 60% of people stop taking iron supplements because of adverse reactions.

Give your stomach a break with ACCRUFeR, an oral iron replacement therapy approved by the FDA for adults with iron deficiency. 

*Hemoglobin is a protein in red blood cells that carries oxygen from the lungs to all parts of the body. Ferritin is a protein that stores iron in your cells and releases iron when your body needs it. TSAT levels are used to determine your body’s iron availability.  

Depending on the progression of your ID or IDA, some of these measures may be more effective indicators than others. For example, low ferritin and TSAT levels are clearer indicators of ID. Low hemoglobin levels may not be detected until ID has progressed to IDA. 

What sets ACCRUFeR apart? 

You deserve a tolerable iron treatment that you can stick with. Here are just a few reasons why ACCRUFeR is iron you’ll actually take: 

• Uniquely formulated with a “maltol shield.” The maltol shield keeps iron protected from the stomach, so it doesn’t break down until it is ready to be absorbed in the small intestine. This minimizes adverse gastrointestinal side effects.
• Unprecedented tolerability. Across studies, less than 5% of patients taking ACCRUFeR discontinued treatment because of adverse GI reactions.*
• Backed by clinical data. ACCRUFeR was proven effective in multiple studies over short-term (12 to 16 weeks) and long-term (52 to 64 weeks) periods. Patients on ACCRUFeR experienced significant improvement in their hemoglobin and iron stores compared with patients on placebo.
• Just enough iron. You take a low, 30-mg dose twice a day. With this dosing, patients in clinical studies did not require IV iron intervention** and treatment did not lead to iron overload.

*Total of 175 patients across studies 

**In long-term studies